On Mar. 26, 2020, Henry Schein announced the availability of an antibody rapid blood test, known as Standard Q COVID-19 IgM/IgG Rapid Test, intended to be administered at the point of care.

The test delivered results within 15 minutes from a pinprick with no instrumentation required.